← Eichor
Condition: Subjects With Hyperuricemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Subjects With Hyperuricemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

GOS and the Management of Hyperuricemia
NA · 1 location(s) · Sun Yat-sen University · NCT06630377The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hy
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07362355A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
Phase 1/Phase 2 · 6 location(s) · Intelligem Therapeutics Australia Pty Ltd. · NCT06310967Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phase 2/Phase 3 · 40 location(s) · Olatec Therapeutics, Inc. · NCT05658575Prebiotics and the Management of Hyperuricemia
NA · 2 location(s) · Sun Yat-sen University · NCT06420401
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.